Skip to content
Luna Metabolic
Menu

We earn commissions; partners may appear first. Disclosure

Science & Co logo

Science & Co review

By Luna Editorial TeamUpdated

Bundled compounded care with twelve-month headline pricing, plus separate Wegovy injection and tablet listings.

What Science & Co costs

Semaglutide
From $59/mo on a 12-month plan; $149 reference shown, flexible quote not confirmed
Tirzepatide
From $99/mo on a 12-month plan; $199 reference shown, flexible quote not confirmed
Where it treats
Not publicly listed
Brand-name GLP-1s
Yes

How Science & Co scores for women

Six women's-health factors, weighted as in our methodology.

PCOS & hormonal suitability72/100
Clinical oversight & labs74/100
Price transparency72/100
Nationwide access62/100
Ongoing support86/100
Cancellation fairness82/100

What we like

  • Evaluation, medication, supplies, shipping and ongoing support advertised together
  • No dose-related price increase on the compounded plans
  • Names its role separately from independent clinicians and dispensing pharmacies
  • Separate approved-brand Wegovy injection and tablet listings

The caveats

  • Lowest compounded rates require a twelve-month plan; flexible totals need confirmation
  • Assigned compounding pharmacy is not named on the treatment page
  • Hormone page reviewed is male testosterone and coming soon, not active menopause care
  • Cancellation requires 72 hours before processing; prescription returns are excluded

The full review

Science & Co makes its compounded GLP-1 offer unusually easy to understand in one respect: the advertised price includes the clinical evaluation, medication, supplies, shipping and continued support. The harder part is the commitment. Its lowest semaglutide and tirzepatide prices belong to twelve-month plans, while the public pages show substantially higher reference prices alongside them.

For women, this is a general weight-management service. The hormone section should not be mistaken for an active menopause clinic: the testosterone page we reviewed describes treatment for men and is labeled coming soon. This review evaluates the published offer, including the limitations that matter before choosing a long plan.

What does Science & Co cost?

The current semaglutide injection page advertises $59 per month on the twelve-month plan, alongside a $149 reference price. Tirzepatide advertises $99 per month on the twelve-month plan, alongside $199. These replace older advertised annual starting figures of $79 and $125. The FAQ explicitly ties the lowest prices to the twelve-month option, so they are not flexible monthly purchase prices.

The pages say the price stays the same at any prescribed dose, with no separate monthly membership and free shipping. That can make budgeting simpler if the clinician increases your prescribed dose. It does not eliminate the need to check the amount actually charged, the supply provided and the renewal interval for the selected plan. The product pages do not present a complete three-, six- and twelve-month checkout ladder in the text reviewed.

An annual monthly equivalent is useful only when you can comfortably accept the associated payment and cancellation conditions. Before selecting $59 or $99, ask whether the full term is collected upfront, whether the term renews automatically and how unused treatment is handled if your clinician changes the plan. Multiplying a headline by twelve does not establish the actual charge without those checkout terms.

Science & Co describes the service as cash-pay, with no insurance claims or prior authorizations. HSA and FSA eligibility is advertised, but your account administrator determines whether a particular expense qualifies. Anyone whose main goal is using insurance for an approved brand should establish the separate brand offer and total cost rather than budget from the compounded price.

Who provides the care and medication?

The terms identify Science and Co, Inc. as a technology and administrative platform, separate from the independent clinicians and pharmacies. The company explicitly says it is not a 503A or 503B compounding facility. That is useful role disclosure; it is not the name of the pharmacy preparing your prescription.

The product pages describe state-licensed U.S. compounding pharmacies, third-party testing and the ability to request a certificate of analysis. Ask which pharmacy will fill your order and what that certificate covers. A testing statement does not make a compounded preparation FDA-approved or establish the results of an individual patient's treatment. The site itself acknowledges that compounded medications are not FDA-reviewed for safety, effectiveness or quality.

The intake is an online health questionnaire reviewed by a licensed provider, with most reviews described as taking 24–48 hours. The illustrations include pregnancy or nursing questions and a thyroid-history prompt. Those screens show the sort of history being gathered; they do not prove that every applicant receives a live visit or the same clinical plan. Approval remains the clinician's decision.

Plans include secure messaging, scheduled check-ins and dose adjustments when clinically appropriate. The page advertises access to the care team at any hour, but it does not publish a guaranteed response time for an urgent clinical concern. Before starting, find out how routine refill questions differ from medical messages and who handles a problem that cannot wait for a portal reply.

What should women clarify?

The weight-loss pages are not a dedicated PCOS pathway. They do not describe management of irregular bleeding, fertility care or a complete endocrine evaluation. A woman whose main concern is PCOS should ask whether the prescriber will coordinate with her existing clinician and which outcomes besides weight will be followed. Our GLP-1 and PCOS guide explains the broader care questions behind that distinction.

Likewise, the hormone-navigation label is not evidence of menopause hormone therapy being available now. The reviewed testosterone product is for men with laboratory-confirmed low levels and is marked coming soon. A woman seeking estradiol, progesterone or integrated menopause care should get a specific service confirmation before enrolling for weight treatment. A broad wellness menu does not establish that these prescriptions will be managed together.

The current catalog also has separate Wegovy injection and Wegovy tablet pages, describing sealed manufacturer medication rather than compounds. Their prices are not established by the compounded-plan headline.

The site labels its laboratory section coming soon. That does not tell you whether your GLP-1 clinician might require an outside test or review recent results. Ask who orders and pays for any necessary bloodwork, and whether results from your regular doctor can be used. Bring your hormone prescriptions, contraception and other medication history to the assessment; our birth-control guide can help you prepare relevant questions.

Shipping, stopping and switching

Shipping is included after clinical review and prescription issuance. The shipping policy distinguishes payment from dispatch, and promises tracking once the order leaves the pharmacy. It also addresses lost or damaged packages and temperature-sensitive delays. Have the care team confirm what to do if a shipment is late rather than interpreting a general delivery estimate as storage advice.

Subscriptions renew at the interval shown at checkout. The stated cancellation cutoff is 72 hours before the processing date, through the account or support email. Canceling stops future orders; it does not reverse an order already prescribed, dispensed or shipped. The thirty-day return window on the policy page applies to unopened non-prescription products, not a general right to return prescription medication.

Science & Co is most attractive when a woman wants a bundled cash-pay compounded program, understands the annual offer and values clear cancellation timing. Its weaker points are the unlisted assigned pharmacy, incomplete public payment ladder and limited women's specialty detail. Compare those specifics with the shorter commitment options in our provider-selection guide, rather than choosing entirely from the lowest monthly headline.

Our verdict on Science & Co

Best for: Women comparing a longer cash-pay GLP-1 plan who will confirm the actual commitment and brand pricing.

Listed #71 of 88 providers we reviewed for women — compare with CoreAge Rx. Nationwide access is where Science & Co scores lowest, at 62/100. If that is your sticking point, start with what women pick instead of Science & Co.

Related guides

Others in Science & Co's score range

The providers scoring closest to Science & Co on the same six factors. One of those comparisons is written out in full: Science & Co vs CoreAge Rx for women, 19 points apart on the Luna Fit Score. Directly below Science & Co sits HealthSource at #72 with 74/100 — see the alternatives to HealthSource we rank for women if that is the band you are shopping in.

See all 88 providers we've reviewed for women — scored on the same rubric, with prices side by side.

Prices and states reflect Science & Co's own public pages when we last checked them; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on Science & Co's site. Not medical advice; see our disclosure.